Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]
Titel:
Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]